期刊文献+

组蛋白去乙酰化酶2表达下调对喉鳞癌Hep-2细胞凋亡和增殖及迁移的影响 被引量:3

Down-regulation of histone deacetylase 2 induces cell apoptosis and inhibits cell proliferation and migration of laryngeal squamous cell carcinoma cells
原文传递
导出
摘要 目的探讨组蛋白去乙酰化酶2(HDAC2)表达下调对喉鳞癌Hep-2细胞增殖、细胞凋亡和细胞迁移的影响。方法利用脂质体2000将HDAC2小干扰RNA(siRNA)和对照siRNA转染喉鳞癌Hep-2细胞,将细胞分为3组:未处理组、siRNA对照组和HDAC2siRNA转染组。利用Westernblot检测转染HDAC2siRNA后喉鳞癌Hep-2细胞中HDAC2蛋白的表达;利用CCK-8分析3组细胞增殖的变化;采用流式细胞术检测3组细胞凋亡情况;接着利用Boyden小室研究3组细胞迁移能力的变化,最后采用Westernblot研究与细胞凋亡和细胞迁移密切相关蛋白的表达。结果HDAC2siRNA明显下调喉鳞癌Hep-2细胞中HDAC2蛋白的表达。HDAC2表达下调明显抑制喉鳞癌Hep-2细胞的增殖和诱导细胞凋亡,并抑制喉鳞癌Hep-2细胞的迁移。此外,HDAC2表达下调明显增加caspase-3和caspase-9的表达,但降低基质金属蛋白酶(MMP)-2和MMP-9的表达。结论HDAC2可能在喉鳞癌发生发展中发挥重要作用,其表达下调介导的细胞凋亡和迁移抑制可能与caspase-3和caspase-9表达的升高以及MMP-2和MMP-9表达的降低相关。 Objective To investigate the effects of histone deacetylase 2 (HDAC2) expression on cell proliferation, apoptosis and migration of laryngeal squamous cell carcinoma (LSCC) Hep-2 cells. Methods HDAC2 siRNA and control siRNA were transfected into LSCC Hep-2 cells by lipofectamine 2000, and ceils were divided into three experimental groups: untreated group, control siRNA group and HDAC2 siRNA transfecfion group. Western blotting was utilized to detect the expression of HDAC2 protein in Hep-2 cells. Cell proliferation and apoptosis were investigated by CCK-8 kit and flow cytometry, respectively. Boyden chamber was used to study cell migration. Expressions of cell apoptosis and cell migration related proteins were detected by Western blotting. Results HDAC2 siRNA significantly down- regulated the expression of HDAC2 protein in LSCC Hep-2 cells. Down-regulation of HDAC2 expression coincided with an inhibition of cell proliferation and migration along with an induced cell apoptosis of Hep-2 cells. Moreover, down-regulation of HDAC2 expression significantly increased the expressions of caspase-3 and caspase-9 proteins but decreased the expressions of matrix metalloproteinases ( MMP)-2 and MMP-9 proteins. Conclusions HDAC2 may play a pivotal role in the initiation and development of LSCC. Downregulation of HDAC2 expression mediates cell apoptosis. Cell migration inhibition may be tightly associated with overexpression of caspase-3 and caspase-9 along with down-regulation of MMP-2 and MMP-9 expressions.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2012年第6期396-399,共4页 Chinese Journal of Pathology
关键词 喉肿瘤 鳞状细胞 细胞系 肿瘤 Laryngeal neoplasms Carcinoma, squamous cell Cells line,tumor
  • 相关文献

参考文献16

  • 1Sanderson RJ, Ironside JA. Squamous cell carcinomas of the head and neck. BMJ, 2002, 325(7368):822-827.
  • 2Robin PE, Reid A, Powell DJ, et al. The incidence of cancer of the larynx. Clin Otolaryngol Allied Sci, 1991,16 (2) : 198-201.
  • 3Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet, 2009, 10( 1 ) :32-42.
  • 4Mutze K, Langer R, Becker K, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol, 2010, 17(12) :3336-3343.
  • 5Langer R, Mutze K, Becker K, et al. Expression of class I histone deacetylases ( HDAC1 and HDAC2 ) in oesophageal adenocarcinomas: an immunohistoehemical study. J Clin Pathol, 2010, 63(11):994-998.
  • 6Adams H, Fritzsche FR, Dirnhofer S, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin' s lymphoma. Expert Opin Ther Targets, 2010,14 (6) :577-584.
  • 7Fritzsche FR, Weichert W, Roske A, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer, 2008, 8:381.
  • 8Weichert W, Roske A, Gekeler V, et al. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer, 2008, 98 (3) :604-610.
  • 9Chang HH, Chiang CP, Hung HC, et al. Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol, 2009, 45(7):6104514.
  • 10Marshall GM, Gherardi S, Xu N, et al. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene, 2010, 29(44) :5957-5968.

二级参考文献1

共引文献3

同被引文献33

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61 (2) : 69-90.
  • 2Pectasides D, Kamposioras K, Papaxoinis G, et al. Chemotherapy for recurrent cervical cancer. Cancer Treat Rev, 2008, 34 (7) : 603-613.
  • 3Yang XJ, Seto E. The Rpd3/Hdal family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol, 2008, 9(3) :206-218.
  • 4Spange S, Wagner T, Heinzel T, et al. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol, 2009, 41 (1) : 185-198.
  • 5Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet, 2009, 10(1) : 32-42.
  • 6Bieliauskas AV, Pflum MK. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev, 2008, 37(7) : 1402-1413.
  • 7Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett, 2009, 280(2) : 168-176.
  • 8Chang HH, Chiang CP, Hung HC, et al. Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol, 2009, 45(7): 610-614.
  • 9Chang CC, Lin BR, Chen ST, et al. HDAC2 promotes cell migration/invasion abilities through HIF-lα stabilization in human oral squamous cell carcinoma. J Oral Pathol Med, 2011,40(7) : 567 -575.
  • 10Fritzsche FR, Weichert W, RSske A, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer, 2008, 8: 381.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部